Medtronic Expands Acute Care Monitoring Wearables Portfolio Through Corsano Distribution Agreement


Published: 12 Jun 2026

Author: Rohan Patil

Share : linkedin twitter facebook

According to Precedence Research, the global remote neurological monitoring market size was estimated at USD 2.45 billion in 2025 and is predicted to increase from USD 2.45 billion in 2026 to approximately USD 9.69 billion by 2035, expanding at a CAGR of 14.80% from 2026 to 2035. The market is driven by the rising integration of artificial intelligence (AI) and cloud analytics, which enable for real-time predictive care and also early detection of neurodegenerative diseases outside traditional hospital settings.

Medtronic

Key Points

  • Medtronic announced a distribution agreement to expand its acute care monitoring wearables portfolio in the United States via the addition of Corsano’s multi-parameter wearable technology.
  • The Corsano wearable is programmed to continuously monitor key physiological parameters, including heart rate, oxygen saturation (SpOâ‚‚), respiratory rate, skin temperature, and physical activity.
  • The device supports remote patient monitoring by allowing healthcare providers to track patients both within healthcare facilities and after discharge, assisting in improving continuity of care.
  • The agreement reflects the growing industry trend toward wearable-based monitoring solutions, which facilitate early detection of patient deterioration and support proactive clinical decision-making.
  • By incorporating Corsano’s technology into its monitoring portfolio, Medtronic thus strengthens its position in the rapidly expanding remote patient monitoring and connected healthcare markets.
  • The wearable provides a comfortable, lightweight design intended for long-term use, improving patient compliance and enabling continuous data collection.
  • The partnership aligns with the healthcare industry's change toward hospital-at-home models and remote care programs, which aim to decrease hospital stays, improve resource utilization, and improve patient outcomes.
  • While the device is not specifically designed for neurological monitoring, the advancement demonstrates broader acceptance of wearable technologies that may support care for patients with neurological disorders via continuous tracking of vital signs and overall health status.
  • The development highlights increasing investment in digital health ecosystems that integrate wearable sensors, data analytics, and even remote monitoring platforms to deliver more personalized and data-driven patient care.
  • Overall, the agreement underscores the increasing importance of wearable monitoring technologies in modern healthcare and thus, their role in enabling scalable, continuous, and patient-centered monitoring solutions.

Latest News